Disseminated Intravascular Coagulopathy (DIC)
35 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary purpose of heparin as an anticoagulant drug?

  • To enhance liver function
  • To promote coagulation factors
  • To bind and neutralize factors II and X (correct)
  • To increase platelet aggregation
  • What medication is NOT indicated in the treatment of DIC?

  • Broad spectrum antibiotics
  • Antifibrinolytics (correct)
  • Hepatoprotectant medications
  • Supportive care
  • In the case of Jude, which laboratory findings indicated a severe inflammatory response?

  • Vast quantities of degenerate neutrophils (correct)
  • No abnormal abdominal ultrasound findings
  • Presence of normal neutrophils
  • Isolated intracellular bacteria without inflammation
  • What should be assessed to determine the treatment approach for DIC?

    <p>Clinical status, progression, and coagulation tests</p> Signup and view all the answers

    Which antibiotics were prescribed for Jude's treatment?

    <p>Ampicillin and Enrofloxacin</p> Signup and view all the answers

    What was the primary presenting complaint of the patient?

    <p>Fever</p> Signup and view all the answers

    What is the most notable laboratory finding in this case?

    <p>Elevated white blood cell count</p> Signup and view all the answers

    Which of the following is NOT a component of the workup plan for this patient?

    <p>Liver biopsy</p> Signup and view all the answers

    What is a proposed medical treatment to address underlying causes in cases like this?

    <p>Administration of antibiotics if necessary</p> Signup and view all the answers

    Which supportive care measure is recommended?

    <p>Oxygen delivery support</p> Signup and view all the answers

    What is a critical component to manage if the patient is experiencing hemorrhage?

    <p>Fresh frozen plasma administration</p> Signup and view all the answers

    In which situation would anticoagulation be considered?

    <p>High-risk patients with overt thrombosis</p> Signup and view all the answers

    What percentage of neutrophils was recorded in the patient’s lab data?

    <p>84%</p> Signup and view all the answers

    What is the initial trigger for inappropriate coagulation in the clinical syndrome described?

    <p>Inflammation caused by disease</p> Signup and view all the answers

    Which of the following factors contributes to platelet adhesion?

    <p>Collagen</p> Signup and view all the answers

    What is the primary outcome when thrombin production outstrips the available coagulation factors?

    <p>Inappropriate bleeding</p> Signup and view all the answers

    What role do endogenous anticoagulant molecules play in coagulation?

    <p>They support clot breakdown and restoration of blood flow.</p> Signup and view all the answers

    Which cells are primarily responsible for triggering thrombin production?

    <p>Monocytes</p> Signup and view all the answers

    What happens to the endothelial glycocalyx during coagulation?

    <p>It becomes degraded, exposing cell adhesion molecules.</p> Signup and view all the answers

    Which of the following is a component of the endothelial glycocalyx?

    <p>Integrins</p> Signup and view all the answers

    What is a consequence of platelet aggregation into microclots?

    <p>Obstruction of arterial flow to organs</p> Signup and view all the answers

    What characterizes DIC as an acquired syndrome?

    <p>Intravascular activation of coagulation</p> Signup and view all the answers

    Which of the following conditions is NOT associated with DIC?

    <p>Gallbladder disease</p> Signup and view all the answers

    During which phase does non-overt DIC predominantly exhibit a hypercoagulable state?

    <p>Compensated activated phase</p> Signup and view all the answers

    What is a hallmark finding in overt DIC?

    <p>Thrombocytopenia</p> Signup and view all the answers

    Which laboratory indicator is used for diagnosing DIC?

    <p>Platelet count</p> Signup and view all the answers

    Which of the following coagulation times indicates non-overt DIC?

    <p>Normal PT</p> Signup and view all the answers

    What does increased D-dimer levels indicate in the context of DIC?

    <p>Increased clot formation</p> Signup and view all the answers

    Which physiological response is a sign of systemic inflammation related to DIC?

    <p>Tachycardia</p> Signup and view all the answers

    In what state is fibrinogen concentration during non-overt DIC?

    <p>Increased due to inflammation</p> Signup and view all the answers

    Which of the following might worsen hemorrhaging in overt DIC?

    <p>Activation of fibrinolysis</p> Signup and view all the answers

    Which protein is crucial in deactivating coagulation factors?

    <p>Antithrombin</p> Signup and view all the answers

    What treatment approach is suggested for managing DIC?

    <p>Eliminating the underlying cause of DIC</p> Signup and view all the answers

    Which clinical sign is characteristic of thrombocytopenia in overt DIC?

    <p>Petechiae</p> Signup and view all the answers

    What does activating tissue factor pathway inhibitor (TFPI) do in the context of DIC?

    <p>Inhibits clot formation</p> Signup and view all the answers

    Study Notes

    Disseminated Intravascular Coagulopathy (DIC)

    • A clinical syndrome where inflammation triggered by disease triggers inappropriate activation of coagulation
    • Activation of coagulation leads to platelet activation and thrombin formation, causing aggregation into microclots
    • Platelets travel to organs, obstructing arterial flow, potentially damaging organs
    • Continuous thrombin production depletes coagulation factors, ultimately preventing clot formation leading to bleeding
    • Platelet adhesion is supported through connections with von Willebrand Factor, Collagen and Fibrinogen
    • Endogenous anticoagulant molecules such as antithrombin, Protein C/S, and Tissue Factor Pathway Inhibitor (TFPI) play a critical role in regulating coagulation

    How Coagulation Occurs Without Tissue Damage

    • Monocytes or other cells initiate thrombin production
    • Tissue factor expression on cells
    • Exposure of adhesion molecules on endothelial surfaces by degradation of endothelial glycocalyx
    • Cell adhesion molecules

    Endogenous Anticoagulant Molecules

    • Antithrombin
    • Protein C/S
    • Tissue Factor Pathway Inhibitor (TFPI)

    Fibrinolysis

    • Triggered by clot formation
    • Allows clot breakdown and restoration of blood flow through plasmin/plasminogen

    DIC Types

    Non-Ovet DIC

    • Activation of coagulation is buffered by anticoagulant mechanisms (i.e. thrombin-antithrombin, Tissue factor and Tissue Factor Pathway Inhibitor).
    • Predominantly hypercoagulable at this time
    • Increased fibrinogen due to inflammation
    • Risk of thrombosis/thromboembolism

    Overt DIC

    • The body's compensatory mechanisms are exceeded, leading to:
    • Thrombocytopenia
    • Decreased fibrinogen levels (and other clotting factors)
    • Hemorrhagic phenotype (petechiae, ecchymoses, epistaxis, and cavitary bleeding)
    • Activation of fibrinolysis worsens hemorrhage
    • Organ failure due to previously formed clots

    DIC Diagnosis

    Platelets

    • Consumptive thrombocytopenia (platelet count between 40-100 x 10³/μL (canine))
    • Platelet clumping observed on blood smear

    Coagulation Profile

    • Prothrombin time (PT)
    • Activated partial thromboplastin time (aPTT): Prolonged
    • Fibrinogen concentration: Decreased with consumption

    Fibrinolysis Markers

    • D-dimer: Increased in circulation
    • FDP: No longer measured

    Decreased Anticoagulant Proteins

    • Protein C/Protein S
    • Antithrombin
    • Tissue Factor Pathway Inhibitor (TFPI)

    DIC Diagnosis: Systemic Inflammation

    • Systemic Inflammatory Response Syndrome (SIRS) criteria (rectal temperature, heart rate, respiratory rate, and blood pressure)
    • Evidence of predisposing disease (e.g., snake bite, organ volvulus, neoplasia)

    Plan/Overall Treatment

    • Identify the inciting cause to initiate treatment
    • Eliminate the inciting cause
    • Treat treatable conditions
    • Replace fibrinogen/clotting factors if bleeding
    • Consider anticoagulation if clotting

    DIC Treatment

    • Resolve underlying cause by providing medical or surgical treatment:
      • Antibiotics (if infection present)
      • Supportive care (e.g., fluids, RBC transfusions, oxygen support)
      • Preventing additional inflammation
      • Drain/flush/remove inflammatory areas (if needed, e.g.abscess, neoplasia, septicemia)
    • Stop hemorrhage if present with fresh frozen plasma or whole blood
    • Decrease overt coagulation if present by evaluating high-risk patients (e.g., IMHA, cardiac disease, severe sepsis, severe sustained systemic inflammation, colitis, or ischemia/shock) and considering the risks/benefits

    Prophylactic Anticoagulation

    • Unfractionated or low-molecular weight heparins to bind and neutralize factors II and X
    • Antiplatelet drugs (No evidence in DIC)

    Additional Laboratory Findings for DIC Diagnosis

    • Platelet counts
    • Coagulation times
    • Indicators of fibrinolysis
    • Evidence of RBC fragmentation
    • Indicators of clot formation

    Other Information

    • Liver aspirate: Findings of degenerate neutrophils/bacterial rods/severe inflammation might indicate septic condition
    • Antifibrinolytics: ɛ-aminocaproic acid or tranexamic acid may be indicated in some rare cases where hyperfibrinolysis is a significant factor.
    • Treatment Decisions: Treatment decisions need to be individualized based on the patient's clinical status, risk factors, and coagulation/fibrinolytic test results and monitored closely (e.g., coagulation status, oxygen delivery, and organ function).

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz covers the clinical syndrome of Disseminated Intravascular Coagulopathy (DIC), focusing on its pathophysiology, including the inappropriate activation of coagulation, platelet aggregation, and organ damage. Additionally, it explores the mechanisms behind coagulation without tissue damage and the roles of various anticoagulants. Test your knowledge on this critical medical condition.

    Use Quizgecko on...
    Browser
    Browser